COMPASS Pathways (CMPS) Liabilities and Shareholders Equity (2019 - 2026)
COMPASS Pathways (CMPS) posted quarterly Liabilities and Shareholders Equity of $531.7 million for Q1 2026, up 66.62% year-over-year from $319.1 million in Q1 2025, and up 152.79% quarter-over-quarter from $210.3 million in Q4 2025.
COMPASS Pathways (CMPS) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
COMPASS Pathways (CMPS) has reported Liabilities and Shareholders Equity for 8 consecutive years, with $531.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 66.62% year-over-year to $531.7 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 21.97% YoY), while the FY2025 annual figure was $210.3 million, down 1.55% from the prior year.
- Liabilities and Shareholders Equity grew to $531.7 million in Q1 2026 per CMPS's latest filing, from $210.3 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $531.7 million in Q1 2026 and bottomed at $173.3 million in Q1 2023.
- Historically, Liabilities and Shareholders Equity has averaged $267.6 million across 5 years, with a median of $255.6 million in 2025.
- Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity plunged 36.31% — and 2024, when it jumped 78.29%.
- COMPASS Pathways' Liabilities and Shareholders Equity stood at $197.3 million in 2022, then surged by 39.89% to $276.0 million in 2023, then retreated by 22.58% to $213.7 million in 2024, then slipped by 1.55% to $210.3 million in 2025, then soared by 152.79% to $531.7 million in 2026.
- Business Quant data shows CMPS's Liabilities and Shareholders Equity at $531.7 million in Q1 2026, $210.3 million in Q4 2025, and $255.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 63.25 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 30.68 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 7.46 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 17.71 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 5.75 Bn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 15.94 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 5.66 Bn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 1.58 Bn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 3.01 Bn |
| 10 | COMPASS Pathways | 1.83 Bn | 1.83 Bn | - | 504.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 504.56 Mn |
| Mar 31, 2026 | 531.74 Mn |
| Dec 31, 2025 | 210.35 Mn |
| Sep 30, 2025 | 255.61 Mn |
| Jun 30, 2025 | 293.54 Mn |
| Mar 31, 2025 | 319.14 Mn |
| Dec 31, 2024 | 213.67 Mn |
| Sep 30, 2024 | 247.34 Mn |
| Jun 30, 2024 | 278.53 Mn |
| Mar 31, 2024 | 308.99 Mn |
| Dec 31, 2023 | 275.99 Mn |
| Sep 30, 2023 | 299.03 Mn |
| Jun 30, 2023 | 209.83 Mn |
| Mar 31, 2023 | 173.31 Mn |
| Dec 31, 2022 | 197.29 Mn |
| Sep 30, 2022 | 224.52 Mn |
| Jun 30, 2022 | 238.64 Mn |
| Mar 31, 2022 | 272.10 Mn |
| Dec 31, 2021 | 300.90 Mn |
| Sep 30, 2021 | 314.74 Mn |